Cargando…
Risk of bleeding with ticagrelor in elderly patients over 75 years old: A systematic review and meta-analysis
BACKGROUND: Bleeding is an untoward outcome in the management of elderly patients with acute coronary syndrome (ACS). Although the potent oral P2Y12 inhibitor, ticagrelor is clinically beneficial, its association with bleeding events in elderly ACS patients (≥75 years) is poorly understood. METHODS:...
Autores principales: | Alaamri, Shalan, Dalbhi, Sultan Al |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568350/ https://www.ncbi.nlm.nih.gov/pubmed/34871206 http://dx.doi.org/10.1097/MD.0000000000027398 |
Ejemplares similares
-
Angiotensin converting enzyme inhibitors and risk of lung cancer: A systematic review and meta-analysis
por: Batais, Mohammed, et al.
Publicado: (2021) -
Efficacy and safety of ticagrelor monotherapy in patients following percutaneous coronary intervention: A systematic review and meta-analysis
por: Zhang, Wen-bin, et al.
Publicado: (2021) -
Hemocoagulase reduces postoperative bleeding and blood transfusion in cardiac surgical patients: A PRISMA-compliant systematic review and meta-analysis
por: Yao, Yun-Tai, et al.
Publicado: (2019) -
Predictors of bleeding event among elderly patients with mechanical valve replacement using random forest model: A retrospective study
por: Kim, Jisu, et al.
Publicado: (2021) -
Bleeding events associated with fibrinolytic therapy and primary percutaneous coronary intervention in patients with STEMI: A systematic review and meta-analysis of randomized controlled trials
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2016)